🏛️ Verified NIH Record • Updated 2026-01-06
Risk Indicators of Sarcoidosis Evolution-Unified Protocol (NCT05567133)
Development of Clinical Prediction Models for Pulmonary Outcomes in Sarcoidosis
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: University of California, San Francisco
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to develop prediction models that can prognosticate patients with sarcoidosis using clinical data and blood markers that can be obtained during a clinic visit.
Who can join: Review the eligibility criteria below.
Location: University of Maryland — Baltimore, Maryland
Age range: 19 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- University of Maryland — Baltimore, Maryland
- UT Southwestern — Dallas, Texas
📞 Contact the Study Coordinator
Phone: (415) 514-4369
Email: laura.koth@ucsf.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Sarcoidosis, Pulmonary clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.